Aethl Bio, Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Biotech
- Headquarters
- Pittsburgh, PA
- Street
- 100 S Jackson Ave
- Zip
- 15202
Offering
- Total offering
- $5M
- Amount sold
- $1.6M
- First sale
- Jul 14, 2025
- Min investment
- $0
- Securities
- Other
- Federal exemption
- Rule 506(b)
- Investors so far
- 8
How this filing compares
Ranked #15 of 47 Biotech filings in April 2026 by offering amount.
Median Biotech filing in April 2026: $3M. This offering is 1.7× the median.
Other Pennsylvania filings this week: 5280 Waste Group, LLC, GSE Partners Fund I, L.P., Jennison Small/Mid Cap Equity Fund of the Prudential Trust C, Jennison U.S. Small Cap Equity Fund of the Prudential Trust, Keystone Innovation Fund II, L.P.
Leadership
Carmelo Montalvo — Executive Officer (also: Director)
Zachary Richert — Director
Dan Willis — Executive Officer
Melissa Thompson — Executive Officer
Filing details
Aethl Bio, Inc. filed a Form D with the SEC on April 17, 2026.